Patient Confidence Improving but Situation Remains Fluid
Patient sentiment and confidence will play a key role in the COVID-19 orthopedic procedure recovery. What can we learn about patients from the data? Jun 02, 2020
We've found 286 results
Medtronic Anticipates More Severe Declines in Coming Months
The company’s orthopedic revenues for its fiscal fourth quarter fell -35% as it endured an additional month of COVID-related impact in April compared to competitors. May 26, 2020
Seikagaku Grows in FY19 on Strength in U.S. Market
The company grew in FY19 despite COVID-related declines in its fourth quarter, driven by both reimbursement wins and competitive account conversions. May 21, 2020
Orthopedic Pioneer Lends Perspective on Industry Opportunities
Marshall Steele, M.D. shares insights on orthopedics and on how the COVID pandemic may change relationships and contracting strategies. May 20, 2020
Medacta CEO Confident in Orthopedics’ Fundamentals
Mr. Francesco Siccardi opens up about market opportunities, headwinds and strategies for Medacta while dealing with the COVID-19 outbreak. May 20, 2020
Orthopedics to Take Unprecedented Hit from COVID-19, Market Fundamentals Remain Strong
The underlying fundamentals of the orthopedic industry remain unchanged due to COVID-19. However, we should prepare for significant alterations in the market landscape as well as the ways that we interact with colleagues and customers. May 19, 2020
Zebra Medical Vision Gains FDA Clearance for Spine Fracture AI Solution
Zebra-Med secured clearance for a product helping to identify more patients at risk of osteoporosis, as 70% of VCFs are underdetected globally. May 18, 2020
Bone Therapeutics Treats First Patients in Phase III Knee Osteoarthritis Study
The JTA-004 Phase III study is approved in five of seven territories. These are the first patients treated after resumption of clinical activities. May 18, 2020
SeaSpine to Pursue Aggressive Launch Cadence Despite COVID-19
The company was able to offset deeper COVID-related declines on the strength of its advanced DBM portfolio and plans to pursue several alpha launches of new products in 2020. May 14, 2020
Conformis Gets Battered by COVID-19 Procedure Deferrals
Geographic factors and a highly elective portfolio exposed the company to a severe downturn due to COVID-19, with 1Q20 revenue down 20% and April revenues down 95%. May 14, 2020
